RAC 1.27% $1.55 race oncology ltd

Cardioprotection thread, page-81

  1. 19,125 Posts.
    lightbulb Created with Sketch. 6028
    Yes I have considered this in the past. This combo is incredibly effective at treating the cancer, but it comes with a very high cardiac risk. Bisantrene might be able to change this by keeping the anticancer efficacy, but minimising the cardiac damage.

    The complication is the introduction of Enhertu which has upturned the whole HER2 treatment landscape.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.